News

Risk-averse investors often avoid individual stocks, even those of well-established, slow-growth companies like Target ( TGT ...
The IBHG ETF offers a 6.76% yield, focusing on high-yield and BBB-rated bonds, with most holdings below BB, reflecting ...
Today we are positioned to capitalize on areas of the credit market, which should benefit from deregulation, such as banks and select investments in the energy industry.
Nippon India Large Cap Fund targets long-term growth through top 100 large-cap stocks, offering consistent returns and ...
Tariffs have increased uncertainty about technology companies selling physical goods with Chinese supply chains. Find out who is most at risk.
In general, Dividend Kings have been successful companies that generate consistent profits for their shareholders that they ...
Entering trading this week, shares of Iovance Biotherapeutics ( IOVA 4.10%) have crashed by nearly 78% since the start of the ...
Today, I’ll talk about three ETFs to do just that. Silver-rated Avantis International Equity ETF, ticker AVDE, combines a broad international portfolio with modest factor tilts while charging a low ...
In many ways, guaranteed income functions as a psychological firewall. It doesn’t prevent market volatility, but it can ...
Against a backdrop of heightened uncertainty, investors are increasing allocations across fixed income sectors, particularly ...
Outlook highlights areas of opportunity in a world where returns across various asset classes have shifted significantly ...
Learn more about whether Alvotech or Arrowhead Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.